' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

PAHERNIK SASCHA
Universitätsklinik für Urologie

Publikationen | Forscherprofil

199 Publikationen

2019

Beiträge in Fachzeitschriften

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate.
Apostolidis, L; Nientiedt, C; Winkler, EC; Berger, AK; Kratochwil, C; Kaiser, A; Becker, AS; Jäger, D; Hohenfellner, M; Hüttenbrink, C; Pahernik, S; Distler, FA; Grüllich, C;
Oncotarget. 2019; 10(1): 17-29.
Originalarbeiten (Zeitschrift)
Local treatment of renal cell carcinoma
Distler, F; Pahernik, S
ONKOLOGE. 2019; 25(6): 512-516.
Originalarbeiten (Zeitschrift)
[Scrotal oedema: a urological chameleon].
Frodl, A; Cafuta, B; Distler, F; Pandey, A; Pahernik, S;
Aktuelle Urol. 2019;
Originalarbeiten (Zeitschrift)

2018

Beiträge in Fachzeitschriften

Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL.
Dieffenbacher, S; Zschabitz, S; Hofer, L; Hatiboglu, G; Hou, WB; Hohenfellner, M; Duensing, S; Sultmann, H; Pahernik, S; Grullich, C
FUTUR SCI OA. 2018; 4(5): FSO299
Originalarbeiten (Zeitschrift)
Response to Bieko re: Risk of Radiation-Induced Cataracts: Investigation of Radiation Exposure to the Eye Lens During Endourological Procedures.
Distler, F; Hartmann, J; Pahernik, S; Wucherer, M;
J Endourol. 2018; 32(10): 905-906.
Letter
Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound
Ganzer, R; Hadaschik, B; Pahernik, S; Koch, D; Baumunk, D; Kuru, T; Heidenreich, A; Stolzenburg, JU; Schostak, M; Blana, A
J UROLOGY. 2018; 199(4): 983-988.
Originalarbeiten (Zeitschrift)
Risk of Radiation-Induced Cataracts: Investigation of Radiation Exposure to the Eye Lens During Endourologic Procedures.
Hartmann, J; Distler, F; Baumüller, M; Guni, E; Pahernik, S; Wucherer, M;
J Endourol. 2018; 32(10): 897-903.
Originalarbeiten (Zeitschrift)
Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
Vetterlein, MW; Gild, P; Kluth, LA; Seisen, T; Gierth, M; Fritsche, HM; Burger, M; Protzel, C; Hakenberg, OW; von Landenberg, N; Roghmann, F; Noldus, J; Nuhn, P; Pycha, A; Rink, M; Chun, FK; May, M; Fisch, M; Aziz, A;
BJU Int. 2018; 121(1): 101-110.
Originalarbeiten (Zeitschrift)
Genomic features of renal cell carcinoma with venous tumor thrombus.
Warsow, G; Hubschmann, D; Kleinheinz, K; Nientiedt, C; Heller, M; Van Coile, L; Tolstov, Y; Trennheuser, L; Wieczorek, K; Pecqueux, C; Gasch, C; Kuru, T; Nyarangi-Dix, J; Hatiboglu, G; Teber, D; Perner, S; Stenzinger, A; Roth, W; Hadaschik, B; Pahernik, S; Jager, D; Grullich, C; Duensing, A; Eils, R; Schlesner, M; Sultmann, H; Hohenfellner, M; Duensing, S
SCI REP-UK. 2018; 8(1): 7477
Originalarbeiten (Zeitschrift)
Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease.
Zschäbitz, S; Distler, FA; Krieger, B; Wuchter, P; Schäfer-Eckart, K; Jenzer, M; Hohenfellner, M; Dreger, P; Haag, GM; Jäger, D; Pahernik, S; Grüllich, C;
Oncotarget. 2018; 9(32): 22537-22545.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate (NEPC)
Apostolidis, L; Nientiedt, C; Winkler, EC; Berger, AK; Kratochwil, C; Kaiser, A; Jager, D; Hohenfellner, M; Huttenbrink, C; Pahernik, S; Distler, F; Grullich, C
ANN ONCOL. 2018; 29:
Abstracts (Zeitschrift)

2017

Beiträge in Fachzeitschriften

Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy
Dietz, S; Sultmann, H; Du, YJ; Reisinger, E; Riediger, AL; Volckmar, AL; Stenzinger, A; Schlesner, M; Jager, D; Hohenfellner, M; Duensing, S; Grullich, C; Pahernik, S
ONCOTARGET. 2017; 8(43): 74049-74057.
Originalarbeiten (Zeitschrift)
The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction.
Distler, FA; Radtke, JP; Bonekamp, D; Kesch, C; Schlemmer, HP; Wieczorek, K; Kirchner, M; Pahernik, S; Hohenfellner, M; Hadaschik, BA;
J Urol. 2017; 198(3): 575-582.
Originalarbeiten (Zeitschrift)
Collecting Duct (Bellini Duct) Renal Cell Carcinoma: Oncologic Outcome and Therapeutic Management
Du, Y; Pahernik, S; Kwol, M; Fuxius, S; Hadaschik, B; Teber, D; Duensing, S; Kaiser, A; Hohenfellner, M; Grüllich, C
Journal of Cancer Therapy. 2017; 8(5): 413-422.
Originalarbeiten (Zeitschrift)
Prognostic relevance of androgen receptor expression in renal cell carcinomas
Foersch, S; Schindeldecker, M; Keith, M; Tagscherer, KE; Fernandez, A; Stenzel, PJ; Pahernik, S; Hohenfellner, M; Schirmacher, P; Roth, W; Macher-Goeppinger, S
ONCOTARGET. 2017; 8(45): 78545-78555.
Originalarbeiten (Zeitschrift)
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
May, M; Fritsche, HM; Vetterlein, MW; Bastian, PJ; Gierth, M; Nuhn, P; Aziz, A; Fisch, M; Stief, CG; Hohenfellner, M; Wirth, MP; Novotny, V; Hakenberg, OW; Noldus, J; Gilfrich, C; Bolenz, C; Burger, M; Brookman-May, SD;
World J Urol. 2017; 35(2): 24-250.
Originalarbeiten (Zeitschrift)
Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.
May, M; Protzel, C; Vetterlein, MW; Gierth, M; Noldus, J; Karl, A; Grimm, T; Wullich, B; Grimm, MO; Nuhn, P; Bastian, PJ; Roigas, J; Hadaschik, B; Gilfrich, C; Burger, M; Fisch, M; Brookman-May, S; Aziz, A; Hakenberg, OW;
Int Urol Nephrol. 2017; 49(2): 247-254.
Originalarbeiten (Zeitschrift)
Ureterocystoneostomy in complex oncological cases with an "Uebelhoer" modified Boari bladder flap.
Radtke, JP; Korzeniewski, N; Huber, J; Alt, CD; Pahernik, S; Hadaschik, BA; Hohenfellner, M; Teber, D;
Langenbecks Arch Surg. 2017; 402(8):1271-1278
Originalarbeiten (Zeitschrift)
Risk factors of long-term postoperative renal function after partial nephrectomy in a solitary kidney
Zhu, J; Kuru, T; Wei, YQ; Hatiboglu, G; Popeneciu, V; Schoenberg, G; Simpfendorfer, T; Zeier, M; Xin, M; Zhang, X; Hohenfellner, M; Pahernik, S
OPEN LIFE SCI. 2017; 12(1): 481-488.
Originalarbeiten (Zeitschrift)
Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German Centers.
Zschabitz, S; Vallet, S; Hadaschik, B; Debatin, D; Fuxius, S; Karcher, A; Pahernik, S; Spath, C; Duensing, S; Jager, D; Hohenfellner, M; Grullich, C
J CANCER. 2017; 8(4): 507-512.
Originalarbeiten (Zeitschrift)

2016

Beiträge in Fachzeitschriften

Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin, JL; Billia, M; Relle, J; Roethke, MC; Popeneciu, IV; Kuru, TH; Hatiboglu, G; Mueller-Wolf, MB; Motsch, J; Romagnoli, C; Kassam, Z; Harle, CC; Hafron, J; Nandalur, KR; Chronik, BA; Burtnyk, M; Schlemmer, HP; Pahernik, S;
Eur Urol. 2016; 70(3): 447-455.
Originalarbeiten (Zeitschrift)
Local Recurrence After Curative Surgical Treatment of Renal Cell Cancer: A Study of 91 Patients.
Du, Y; Grüllich, C; Hadaschik, B; Hatiboglu, G; Hohenfellner, M; Pahernik, S;
Clin Genitourin Cancer. 2016; 14(4): e379-e385.
Originalarbeiten (Zeitschrift)
Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma.
Du, Y; Pahernik, S; Hadaschik, B; Teber, D; Duensing, S; Jäger, D; Hohenfellner, M; Grüllich, C;
J Neurooncol. 2016; 130(1):221-228
Originalarbeiten (Zeitschrift)
Survival and prognostic factors of patients with renal cell cancer with bone metastasis in the era of targeted therapy: A single-institution analysis.
Du, Y; Pahernik, S; Hadaschik, B; Teber, D; Duensing, S; Jäger, D; Hohenfellner, M; Grüllich, C;
Urol Oncol. 2016; 34(10): 433.e1-433.e8.
Originalarbeiten (Zeitschrift)
Local salvage therapy for late (>= 2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence
Grullich, C; Vallet, S; Hecht, C; Duensing, S; Hadaschik, B; Jager, D; Hohenfellner, M; Pahernik, S
UROL ONCOL-SEMIN ORI. 2016; 34(5): 238.e9-238.17.
Originalarbeiten (Zeitschrift)
Predictive factors for immediate continence after radical prostatectomy.
Hatiboglu, G; Teber, D; Tichy, D; Pahernik, S; Hadaschik, B; Nyarangi-Dix, J; Hohenfellner, M;
World J Urol. 2016; 34(1): 113-120.
Originalarbeiten (Zeitschrift)
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
Hoefflin, R; Lahrmann, B; Warsow, G; Hubschmann, D; Spath, C; Walter, B; Chen, X; Hofer, L; Macher-Goeppinger, S; Tolstov, Y; Korzeniewski, N; Duensing, A; Grullich, C; Jager, D; Perner, S; Schonberg, G; Nyarangi-Dix, J; Isaac, S; Hatiboglu, G; Teber, D; Hadaschik, B; Pahernik, S; Roth, W; Eils, R; Schlesner, M; Sultmann, H; Hohenfellner, M; Grabe, N; Duensing, S
NAT COMMUN. 2016; 7:
Originalarbeiten (Zeitschrift)
The ribosomal protein S6 in renal cell carcinoma: functional relevance and potential as biomarker.
Knoll, M; Macher-Goeppinger, S; Kopitz, J; Duensing, S; Pahernik, S; Hohenfellner, M; Schirmacher, P; Roth, W;
Oncotarget. 2016; 7(1): 418-432.
Originalarbeiten (Zeitschrift)
Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.
Mager, R; Daneshmand, S; Evans, CP; Palou, J; Martínez-Salamanca, JI; Master, VA; McKiernan, JM; Libertino, JA; Haferkamp, A; Haferkamp, A; Capitanio, U; Carballido, JA; Chantada, V; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; González, J; Hohenfellner, M; Huang, WC; Koppie, TM; Libertino, JA; Espinós, EL; Lorentz, A; Martínez-Salamanca, JI; Master, VA; McKiernan, JM; Montorsi, F; Novara, G; O"Malley, P; Pahernik, S; Palou, J; Moreno, JL; Pruthi, RS; Faba, OR; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Tilki, D; Vázquez-Martul, D; Donoso, CV; Vergho, D; Wallen, EM; Zigeuner, R;
J Surg Oncol. 2016; 114(6): 764-768.
Originalarbeiten (Zeitschrift)
Risk factors for long-term outcome in photoselective vaporization of the prostate.
Popeneciu, IV; Hatiboglu, G; Kuru, TH; Milakovic, S; Freier, G; Hadaschik, B; Hohenfellner, M; Pahernik, S;
Scand J Urol. 2016; 50(4): 313-318.
Originalarbeiten (Zeitschrift)
Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance.
Radtke, JP; Kuru, TH; Bonekamp, D; Freitag, MT; Wolf, MB; Alt, CD; Hatiboglu, G; Boxler, S; Pahernik, S; Roth, W; Roethke, MC; Schlemmer, HP; Hohenfellner, M; Hadaschik, BA;
Prostate Cancer Prostatic Dis. 2016; 19(3): 283-291.
Originalarbeiten (Zeitschrift)
A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study.
Thomas, JA; Tubaro, A; Barber, N; d'Ancona, F; Muir, G; Witzsch, U; Grimm, MO; Benejam, J; Stolzenburg, JU; Riddick, A; Pahernik, S; Roelink, H; Ameye, F; Saussine, C; Bruyère, F; Loidl, W; Larner, T; Gogoi, NK; Hindley, R; Muschter, R; Thorpe, A; Shrotri, N; Graham, S; Hamann, M; Miller, K; Schostak, M; Capitán, C; Knispel, H; Bachmann, A;
Eur Urol. 2016; 69(1): 94-102.
Originalarbeiten (Zeitschrift)
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database.
Wolff, I; May, M; Hoschke, B; Zigeuner, R; Cindolo, L; Hutterer, G; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Dalpiaz, O; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Santiago Martin, MD; Salzano, L; Lotrecchiano, G; Shariat, SF; Hohenfellner, M; Waidelich, R; Stief, C; Miller, K; Pahernik, S; Brookman-May, S;
Eur J Surg Oncol. 2016; 42(5): 744-750.
Originalarbeiten (Zeitschrift)
Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project.
Zondervan, PJ; Wagstaff, PG; Desai, MM; de Bruin, DM; Fraga, AF; Hadaschik, BA; Köllermann, J; Liehr, UB; Pahernik, SA; Schlemmer, HP; Wendler, JJ; Algaba, F; de la Rosette, JJ; Laguna Pes, MP;
World J Urol. 2016; 34(12):1657-1665
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Magnetic resonance imaging-guided transurethral ultrasound prostate ablation in patients with localized prostate cancer: 24-month outcomes of a prospective phase I study
Chin, J; Pahernik, S; Schlemmer, HP; Burtnyk, M; Hafron, J; Mueller-Wolf, M; Roethke, M; Popeneciu, IV; Billia, M
INT J UROL. 2016; 23: 61-62.
Abstracts (Zeitschrift)
MAGNETIC RESONANCE IMAGING-GUIDED TRANSURETHRAL ULTRASOUND PROSTATE ABLATION IN PATIENTS WITH LOCALIZED PROSTATE CANCER: 18-MONTH OUTCOMES OF A PROSPECTIVE PHASE I STUDY
Chin, J; Relle, J; Hafron, J; Popeneciu, L; Kuru, T; Billia, M; Siddiqui, K; Roethke, M; Romagnoli, C; Burtnyk, M; Schlemmer, HP; Pahernik, S
J UROLOGY. 2016; 195(4): E201-E201.
Abstracts (Zeitschrift)
IMPACT OF SURGICAL VOLUME ON PERIOPERATIVE OUTCOMES AFTER NEPHRECTOMY WITH TUMOR THROMBECTOMY
Espinos, EL; Martinez-Salamanca, JI; Carballido, J; Gonzalez, J; Capitanio, U; Chantada, V; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Lorentz, A; Master, VA; McKiernan, JM; Montorsi, F; OxxxMalley, P; Pahernik, S; Palou, J; Moreno, JLP; Pruthi, RS; Faba, OR; Russo, P; Scherr, DS; Spahn, M; Terrone, C; Tilki, D; Vazquez-Martul, D; Donoso, CV; Vergho, D; Wallen, EM; Richard, Z; Libertino, JA
J UROLOGY. 2016; 195(4): E835-E835.
Abstracts (Zeitschrift)
Reduced disqualification rates when MRI-targeted transperineal fusion biopsies are used instead of standard 12-core systematic biopsies for selection of prostate cancer patients for active surveillance
Radtke, JP; Kuru, T; Bonekamp, D; Freitag, M; Mueller-Wolf, M; Alt, C; Hatiboglu, G; Boxler, S; Pahernik, S; Roth, W; Roethke, M; Schlemmer, HP; Hohenfellner, M; Hadaschik, B
ONCOL RES TREAT. 2016; 39: 20-20.
Abstracts (Zeitschrift)
FURTHER REDUCTION OF DISQUALIFICATION RATES BY ADDITIONAL MRI-TARGETED BIOPSY WITH TRANSPERINEAL SATURATION BIOPSY COMPARED TO STANDARD 12-CORE SYSTEMATIC BIOPSIES FOR SELECTION OF PROSTATE CANCER PATIENTS FOR ACTIVE SURVEILLANCE
Radtke, JP; Kuru, TH; Bonekamp, D; Freitag, M; Kesch, CV; Wolf, M; Alt, C; Hatiboglu, G; Boxler, S; Pahernik, S; Roth, W; Roethke, MC; Schlemmer, HP; Hohenfellner, M; Hadaschik, B
J UROLOGY. 2016; 195(4): E232-E232.
Abstracts (Zeitschrift)
MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING AND MRI/TRUS-FUSION-BIOPSY FOR INDEX TUMOR DETECTION: CORRELATION WITH RADICAL PROSTATECTOMY SPECIMEN
Radtke, JP; Schwab, C; Wolf, M; Freitag, M; Alt, C; Kesch, CV; Pahernik, S; Bonekamp, D; Roth, W; Schuler, S; Stock, C; Schlemmer, HP; Roethke, MC; Hohenfellner, M; Hadaschik, B
J UROLOGY. 2016; 195(4): E250-E251.
Abstracts (Zeitschrift)

2015

Beiträge in Fachzeitschriften

A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study.
Bachmann, A; Tubaro, A; Barber, N; d"Ancona, F; Muir, G; Witzsch, U; Grimm, MO; Benejam, J; Stolzenburg, JU; Riddick, A; Pahernik, S; Roelink, H; Ameye, F; Saussine, C; Bruyère, F; Loidl, W; Larner, T; Gogoi, NK; Hindley, R; Muschter, R; Thorpe, A; Shrotri, N; Graham, S; Hamann, M; Miller, K; Schostak, M; Capitán, C; Knispel, H; Thomas, JA;
J Urol. 2015; 193(2): 570-578.
Originalarbeiten (Zeitschrift)
Survival after renal cell carcinoma metastasis to the thyroid: single center experience and systematic review of the literature.
Beutner, U; Leowardi, C; Bork, U; Lüthi, C; Tarantino, I; Pahernik, S; Wente, MN; Büchler, MW; Schmied, BM; Müller, SA;
Thyroid. 2015; 25(3): 31-24.
Übersichtsarbeiten
SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer.
Eichelberg, C; Vervenne, WL; De Santis, M; Fischer von Weikersthal, L; Goebell, PJ; Lerchenmüller, C; Zimmermann, U; Bos, MM; Freier, W; Schirrmacher-Memmel, S; Staehler, M; Pahernik, S; Los, M; Schenck, M; Flörcken, A; van Arkel, C; Hauswald, K; Indorf, M; Gottstein, D; Michel, MS;
Eur Urol. 2015; 68(5): 83-47.
Originalarbeiten (Zeitschrift)
Urothelial carcinoma
Fink, SEK; Pahernik, S; Hallscheidt, P; Zeier, M
ONKOLOGE. 2015; 21(8): 739-745.
Originalarbeiten (Zeitschrift)
[Structure of biobanks for urological research].
Hatiboglu, G; Huber, J; Herpel, E; Popeneciu, IV; Nyarangi-Dix, J; Teber, D; Hadaschik, BA; Pahernik, S; Duensing, S; Hohenfellner, M;
Urologe A. 2015; 54(9): 125-160.
Übersichtsarbeiten
[Intratumoral heterogeneity in renal cell carcinoma. Molecular basis and translational implications].
Höfflin, R; Roth, W; Sültmann, H; Grüllich, C; Hatiboglu, G; Nyarangi-Dix, J; Schönberg, G; Teber, D; Hadaschik, B; Pahernik, S; Hohenfellner, M; Duensing, S;
Urologe A. 2015; 54(6): 800-803.
Originalarbeiten (Zeitschrift)
Defined conditions for the isolation and expansion of basal prostate progenitor cells of mouse and human origin.
Höfner, T; Eisen, C; Klein, C; Rigo-Watermeier, T; Goeppinger, SM; Jauch, A; Schoell, B; Vogel, V; Noll, E; Weichert, W; Baccelli, I; Schillert, A; Wagner, S; Pahernik, S; Sprick, MR; Trumpp, A;
Stem Cell Reports. 2015; 4(3): 503-518.
Originalarbeiten (Zeitschrift)
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.
Höfner, T; Vallet, S; Hadaschik, BA; Pahernik, S; Duensing, S; Hohenfellner, M; Jäger, D; Grüllich, C;
World J Urol. 2015; 33(6): 833-839.
Originalarbeiten (Zeitschrift)
Interdisciplinary counseling service for renal malignancies: A patient-centered approach to raise guideline adherence
Huber, J; Ihrig, A; Winkler, E; Brechtel, A; Friederich, HC; Herzog, W; Frank, M; Grullich, C; Hallscheidt, P; Zeier, M; Pahernik, S; Hohenfellner, M
UROL ONCOL-SEMIN ORI. 2015; 33(1): 23.e1-23.e7.
Originalarbeiten (Zeitschrift)
Identification of cell-free microRNAs in the urine of patients with prostate cancer.
Korzeniewski, N; Tosev, G; Pahernik, S; Hadaschik, B; Hohenfellner, M; Duensing, S;
Urol Oncol. 2015; 33(1): 16.e17-16.e22.
Originalarbeiten (Zeitschrift)
PBRM1 (BAF180) protein is functionally regulated by p53-induced protein degradation in renal cell carcinomas.
Macher-Goeppinger, S; Keith, M; Tagscherer, KE; Singer, S; Winkler, J; Hofmann, TG; Pahernik, S; Duensing, S; Hohenfellner, M; Kopitz, J; Schirmacher, P; Roth, W;
J Pathol. 2015; 237(4): 460-471.
Originalarbeiten (Zeitschrift)
Prognostic Significance and Functional Role of CEP57 in Prostate Cancer.
Mang, J; Korzeniewski, N; Dietrich, D; Sailer, V; Tolstov, Y; Searcy, S; von Hardenberg, J; Perner, S; Kristiansen, G; Marx, A; Roth, W; Herpel, E; Grüllich, C; Popeneciu, V; Pahernik, S; Hadaschik, B; Hohenfellner, M; Duensing, S;
Transl Oncol. 2015; 8(6): 487-496.
Originalarbeiten (Zeitschrift)
Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis.
Nguyen, HG; Tilki, D; Dall"Era, MA; Durbin-Johnson, B; Carballido, JA; Chandrasekar, T; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Linares Espinós, E; Mandel, P; Martinez-Salamanca, JI; Master, VA; McKiernan, JM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Rodriguez-Faba, O; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP;
J Urol. 2015; 194(2): 304-308.
Originalarbeiten (Zeitschrift)
Focal therapy of prostate cancer
Pahernik, S; Hadaschik, B; Schlemmer, HP
ONKOLOGE. 2015; 21(9): 797-+.
Originalarbeiten (Zeitschrift)
The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard.
Radtke, JP; Hadaschik, BA; Wolf, MB; Freitag, MT; Schwab, C; Alt, C; Roth, W; Duensing, S; Pahernik, SA; Roethke, MC; Schlemmer, HP; Hohenfellner, M; Teber, D;
J Endourol. 2015; 29(12): 1396-1405.
Originalarbeiten (Zeitschrift)
Evidence from the "PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)" study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer?
Schmid, M; Rink, M; Traumann, M; Bastian, PJ; Bartsch, G; Ellinger, J; Grimm, MO; Hadaschik, B; Haferkamp, A; Hakenberg, OW; Aziz, A; Hartmann, F; Herrmann, E; Hohenfellner, M; Janetschek, G; Gierth, M; Pahernik, Sh; Protzel, C; Roigas, J; Gördük, M; Lusuardi, L; May, M; Trinh, QD; Fisch, M; Chun, FK;
Ann Surg Oncol. 2015; 22(3): 103-142.
Originalarbeiten (Zeitschrift)
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy.
Shahzad, K; Bock, F; Dong, W; Wang, H; Kopf, S; Kohli, S; Al-Dabet, MM; Ranjan, S; Wolter, J; Wacker, C; Biemann, R; Stoyanov, S; Reymann, K; Söderkvist, P; Groß, O; Schwenger, V; Pahernik, S; Nawroth, PP; Gröne, HJ; Madhusudhan, T; Isermann, B;
Kidney Int. 2015; 87(1): 7-84.
Originalarbeiten (Zeitschrift)
Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.
Tilki, D; Hu, B; Nguyen, HG; Dall"Era, MA; Bertini, R; Carballido, JA; Chandrasekar, T; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Linares, E; Lorentz, CA; Mandel, P; Martinez-Salamanca, JI; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Rodriguez Faba, O; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Thieu, W; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP;
J Urol. 2015; 193(2): 436-442.
Originalarbeiten (Zeitschrift)
Primary melanoma of the prostate: case report and review of the literature.
Tosev, G; Kuru, TH; Huber, J; Freier, G; Bergmann, F; Hassel, JC; Pahernik, SA; Hohenfellner, M; Hadaschik, BA;
BMC Urol. 2015; 15: 68
Fallberichte
Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer center.
Vallet, S; Pahernik, S; Höfner, T; Tosev, G; Hadaschik, B; Duensing, S; Sedlaczek, O; Hohenfellner, M; Jäger, D; Grüllich, C;
Clin Genitourin Cancer. 2015; 13(3): e14-e52.
Originalarbeiten (Zeitschrift)
Uncoupling of PUMA Expression and Apoptosis Contributes to Functional Heterogeneity in Renal Cell Carcinoma - Prognostic and Translational Implications.
Zhou, X; Li, J; Marx, C; Tolstov, Y; Rauch, G; Herpel, E; Macher-Goeppinger, S; Roth, W; Grüllich, C; Pahernik, S; Hohenfellner, M; Duensing, S;
Transl Oncol. 2015; 8(6): 480-486.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

A TRANSPLANT-BASED SURGICAL APPROACH MAY IMPROVE POSTOPERATIVE COMPLICATIONS IN CASES OF RENAL CELL CARCINOMA AND TUMOR THROMBUS
Espinos, EL; Gonzalez, J; Martinez-Sala-Manca, JI; Novara, G; Bertini, R; Carballido, J; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, C; Gontero, P; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, T; Lascano, D; Lorentz, A; Mass, AY; Master, V; McKiernan, J; Mir, C; Mlynarczyk, C; Montorsi, F; Nguyen, H; Pahernik, S; Palou, J; Pruthi, R; Rodriguez-Faba, O; Russo, P; Scherr, DS; Shariat, S; Spahn, M; Terrone, C; Tilki, D; Vergho, D; Wallen, E; Zigeuner, R; Libertino, JA
J UROLOGY. 2015; 193(4): E982-E982.
Abstracts (Zeitschrift)
THE SIGNIFICANCE OF SYMPTOMATOLOGY: ANALYSIS FROM THE INTERNATIONAL RENAL CELL CARCINOMA-VENOUS THROMBUS CONSORTIUM (IRCC-VTC)
Pak, JS; Lascano, D; Finkelstein, JB; McKiernan, JM; DeCastro, GJ; Capitanio, U; Carballido, JA; Chantada, V; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Espinos, EL; Lorentz, A; Martinez-Salamanca, JI; Martul, D; Mass, AY; Master, VA; Mir, C; Montorsi, F; Novara, G; OxxxMalley, P; Pahernik, S; Palou, J; Moreno, JLP; Pruthi, RS; Faba, OR; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Tilki, D; Donoso, CV; Vergho, D; Wallen, EM; Zigeuner, R; Libertino, JA
J UROLOGY. 2015; 193(4): E533-E533.
Abstracts (Zeitschrift)
General health and erectile function - is it affected by transurethral resection of the prostate?
Thomas, A; Tubaro, A; Barber, N; DxxxAncona, F; Gordon, M; Witzsch, U; Grimm, MO; Benejam, J; Stolzenburg, JU; Riddick, A; Pahernik, S; Roelink, J; Ameye, F; Saussine, C; Bruyere, F; Loidl, W; Larner, T; Gogoi, N; Hindley, R; Muschter, R; Thorpe, A; Shrotri, N; Graham, S; Hamann, M; Miller, K; Schostak, M; Capitan, C; Knispel, H; Bachmann, A
BJU INT. 2015; 115: 46-47.
Abstracts (Zeitschrift)
Functional results of a prospective randomized controlled study comparing GreenLight XPS to TURP demonstrate durable efficacy and safety at 24-months (GOLIATH)
Thomas, A; Tubaro, A; Barber, N; DxxxAncona, F; Gordon, M; Witzsch, U; Grimm, MO; Benejam, J; Stolzenburg, JU; Riddick, A; Pahernik, S; Roelink, J; Ameye, F; Saussine, C; Bruyere, F; Loidl, W; Larner, T; Gogoi, N; Hindley, R; Muschter, R; Thorpe, A; Shrotri, N; Graham, S; Hamann, M; Miller, K; Schostak, M; Capitan, C; Knispel, H; Bachmann, A
BJU INT. 2015; 115: 45-45.
Abstracts (Zeitschrift)
TRANSURETHRAL RESECTION OF THE PROSTATE (GL-XPS OR TURP) DOES NOT RESULT IN SIGNIFICANT IMPAIRMENT OF ERECTILE FUNCTION
Thomas, JA; Tubaro, A; Barber, N; d'Ancona, F; Muir, G; Witzsch, U; Grimm, MO; Benejam, J; Stolzenburg, JU; Riddick, A; Pahernik, S; Roelink, J; Ameye, F; Saussine, C; Bruyere, F; Loidl, W; Bruyere, F; Loidl, W; Larner, T; Gogoi, N; Hindley, R; Muschter, R; Thorpe, A; Shrotri, N; Graham, S; Hamann, M; Miller, K; Schostak, M; Capitan, C; Knispel, H; Bachmann, A
J UROLOGY. 2015; 193(4): E96-E96.
Abstracts (Zeitschrift)
24-MONTH RESULTS FOR A PROSPECTIVE RANDOMIZED CONTROLLED STUDY COMPARING GREENLIGHT XPS TO TURP DEMONSTRATE DURABILITY OF RESPONSE AT 24-MONTHS
Thomas, JA; Tubaro, A; Barber, N; d'Ancona, F; Muir, G; Witzsch, U; Grimm, MO; Benejam, J; Stolzenburg, JU; Riddick, A; Pahernik, S; Roelink, J; Ameye, F; Saussine, C; Bruyere, F; Loidl, W; Larner, T; Gogoi, N; Hindley, R; Muschter, R; Thorpe, A; Shrotri, N; Graham, S; Hamann, M; Miller, K; Schostak, M; Capitan, C; Knispel, H; Bachmann, A
J UROLOGY. 2015; 193(4): E95-E95.
Abstracts (Zeitschrift)

2014

Beiträge in Fachzeitschriften

180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study.
Bachmann, A; Tubaro, A; Barber, N; d"Ancona, F; Muir, G; Witzsch, U; Grimm, MO; Benejam, J; Stolzenburg, JU; Riddick, A; Pahernik, S; Roelink, H; Ameye, F; Saussine, C; Bruyère, F; Loidl, W; Larner, T; Gogoi, NK; Hindley, R; Muschter, R; Thorpe, A; Shrotri, N; Graham, S; Hamann, M; Miller, K; Schostak, M; Capitán, C; Knispel, H; Thomas, JA;
Eur Urol. 2014; 65(5): 931-942.
Originalarbeiten (Zeitschrift)
Evolving therapeutic concepts in prostate cancer based on genome-wide analyses (review).
Georgi, B; Korzeniewski, N; Hadaschik, B; Grüllich, C; Roth, W; Sültmann, H; Pahernik, S; Hohenfellner, M; Duensing, S;
Int J Oncol. 2014; 45(4): 1337-1344.
Übersichtsarbeiten
The impact of type 2 diabetes on the outcome of localized renal cell carcinoma.
Höfner, T; Zeier, M; Hatiboglu, G; Eisen, C; Schönberg, G; Hadaschik, B; Teber, D; Duensing, S; Trumpp, A; Hohenfellner, M; Pahernik, S;
World J Urol. 2014; 32(6): 1537-1542.
Originalarbeiten (Zeitschrift)
Does a venous tumor thrombus exclude renal transitional cell carcinoma? Implications for neo-adjuvant treatment strategies.
Huber, J; Teber, D; Hatiboglu, G; Popeneciu, V; Jakobi, H; Hallscheidt, P; Pahernik, S; Hohenfellner, M;

Preoperative decision making for renal cell carcinoma: Cystic morphology in cross-sectional imaging might predict lower malignant potential
Huber, J; Winkler, A; Jakobi, H; Bruckner, T; Roth, W; Hallscheidt, P; Daneshvar, K; Hohenfellner, M; Pahernik, S
UROL ONCOL-SEMIN ORI. 2014; 32(1):
Originalarbeiten (Zeitschrift)
Volumetry may predict early renal function after nephron sparing surgery in solitary kidney patients.
Kuru, TH; Zhu, J; Popeneciu, IV; Rudhardt, NS; Hadaschik, BA; Teber, D; Roethke, M; Hohenfellner, M; Zeier, M; Pahernik, SA;

Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
Martínez-Salamanca, JI; Linares, E; González, J; Bertini, R; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Nguyen, HG; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Faba, OR; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Tilki, D; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA;

[Nephrectomy: complication management].
Pahernik, S; Bergsträßer, C; Teber, D; Hohenfellner, M;

Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma.
Schneider, M; Schüler, J; Höfflin, R; Korzeniewski, N; Grüllich, C; Roth, W; Teber, D; Hadaschik, B; Pahernik, S; Hohenfellner, M; Duensing, S;

Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
Tilki, D; Nguyen, HG; Dall"Era, MA; Bertini, R; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Lorentz, CA; Mandel, P; Martinez-Salamanca, JI; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Rodriguez Faba, O; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP;
Eur Urol. 2014; 66(3):577-583
Originalarbeiten (Zeitschrift)
Human papillomaviruses in urological malignancies: A critical assessment
Tolstov, Y; Hadaschik, B; Pahernik, S; Hohenfellner, M; Duensing, S
UROL ONCOL-SEMIN ORI. 2014; 32(1):
Übersichtsarbeiten
Focal therapy in prostate cancer: international multidisciplinary consensus on trial design.
van den Bos, W; Muller, BG; Ahmed, H; Bangma, CH; Barret, E; Crouzet, S; Eggener, SE; Gill, IS; Joniau, S; Kovacs, G; Pahernik, S; de la Rosette, JJ; Rouvière, O; Salomon, G; Ward, JF; Scardino, PT;
Eur Urol. 2014; 65(6):107-183
Originalarbeiten (Zeitschrift)
Harnessing the p53-PUMA axis to overcome DNA damage resistance in renal cell carcinoma.
Zhou, X; Tolstov, Y; Arslan, A; Roth, W; Grüllich, C; Pahernik, S; Hohenfellner, M; Duensing, S;

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

PROSPECTIVE RANDOMIZED CONTROLLED TRIAL COMPARING GREENLIGHT (GL) 180-W XPS PVP AND TRANSURETHRAL RESECTION OF THE PROSTATE (THE GOLIATH STUDY): ONE YEAR FOLLOW-UP BY PROSTATE SIZE.
Bachmann, A; Tubaro, A; Barber, N; dxxxAncona, F; Muir, G; Witzsch, U; Grimm, MO; Benejam, J; Stolzenburg, JU; Pahernik, S; Riddick, A; Roelink, J; Ameye, F; Thomas, A
J UROLOGY. 2014; 191(4): E796-E796.
Abstracts (Zeitschrift)
MAGNETIC RESONANCE IMAGING (MRI)-GUIDED TRANSURETHRAL ULTRASOUND ABLATION OF PROSTATE CANCER: PRELIMINARY OUTCOMES OF A PHASE I CLINICAL TRIAL
Billia, M; Burtnyk, M; Kuru, T; Pahernik, S; Roethke, M; Schlemmer, HP; Romagnoli, C; Chin, J
J UROLOGY. 2014; 191(4): E718-E719.
Abstracts (Zeitschrift)
IMPACT OF MICROSCOPIC VEIN INVASION ON CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND TUMOR THROMBUS
Faba, OR; Martnez, JI; Tilki, D; DallxxxEra, MA; Nguyen, HG; Roberto, B; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Hu, B; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Lorentz, A; Mandel, P; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Novara, G; Pahernik, S; Pruthi, RS; Ramaswamy, K; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP; Palou, J
J UROLOGY. 2014; 191(4): E318-E319.
Abstracts (Zeitschrift)
Subgroup analyses of a randomized sequential open-label study (SWITCH) to evaluate efficacy and safety of sorafenib (SO)/sunitinib (SU) versus SU/SO in the treatment of metastatic renal cell cancer (mRCC)
Goebell, PJ; Vervenne, W; De Santis, M; Von Weikersthal, LF; Lerchenmuller, CA; Zimmermann, U; Bos, MMEM; Freier, W; Schirrmacher-Memmel, S; Staehler, MD; Pahernik, S; Los, M; Schenk, M; Florcken, A; Van Arkel, C; Hauswald, K; Indorf, M; Gottstein, D; Eichelberg, C; Michel, MS
J CLIN ONCOL. 2014; 32(15):
Abstracts (Zeitschrift)
"RISK FACTORS" FOR IMMEDIATE CONTINENCE AFTER RADICAL PROSTATECTOMY
Hatiboglu, G; Nyarangi-Dix, J; Pahernik, S; Teber, D; Hadaschik, B; Hohenfellner, M
J UROLOGY. 2014; 191(4): E518-E518.
Abstracts (Zeitschrift)
Urothelial cell and lung cancer: An epidemiologic and clinical analysis of their coincidence
Keck, B; Wullich, B; Giedl, J; Walter, B; Kraywinkel, K; Dahm, S; Pahernik, S; Hohenfellner, M; Petsch, S; Klug, SJ; Novotny, V; Wirth, M; Huber, J
ONCOL RES TREAT. 2014; 37: 65-65.
Abstracts (Zeitschrift)
CANCER-SPECIFIC SURVIVAL AND PREDICTORS IN PATIENTS WITH CT3B KIDNEY CANCER: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM
Linares, E; Martinez-Salamanca, JI; Novara, G; Bertini, R; Carballido, J; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, C; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, T; Lorentz, A; Ballesteros, CM; Master, V; Matloob, R; McKiernan, J; Mlynarczyk, C; Montorsi, F; Nguyen, H; Pahernik, S; Palou, J; Pruthi, R; Ramaswamy, K; Rodriguez-Faba, O; Russo, P; Spahn, M; Shariat, S; Terrone, C; Tilki, D; Vergho, D; Volpe, A; Wallen, E; Xylinas, E; Zigeuner, R; Libertino, JA
J UROLOGY. 2014; 191(4): E646-E646.
Abstracts (Zeitschrift)
SWITCH: A randomized sequential open-label study to evaluate efficacy and safety of sorafenib (SO)/sunitinib (SU) versus SU/SO in the treatment of metastatic renal cell cancer (mRCC)
Michel, MS; Vervenne, W; de Santis, M; von Weikersthal, LF; Goebell, PJ; Lerchenmueller, J; Zimmermann, U; Bos, MMEM; Freier, W; Schirrmacher-Memmel, S; Staehler, MD; Pahernik, S; Los, M; Schenck, M; Florcken, A; Van Arkel, C; Hauswald, K; Indorf, M; Gottstein, D; Eichelberg, C
J CLIN ONCOL. 2014; 32(4):
Abstracts (Zeitschrift)
DOES THE USE OF CARDIOPULMONARY BY-PASS (CPB) IMPACT SURVIVAL IN PATIENTS UNDERGOING NEPHRECTOMY/LEVEL III-IV TUMOR THROMBECTOMY? A MULTI-INSTITUTIONAL ANALYSIS
Nguyen, H; Tilki, D; DallxxxEra, M; Bertini, R; Carballido, J; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, W; Koppie, T; Lorentz, A; Mandel, P; Martinez-Salamanca, J; Master, V; Matloob, R; McKiernan, J; Mlynarczyk, C; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, R; Ramaswamy, K; Faba, OR; Russo, P; Shariat, S; Spahn, M; Terrone, C; Vergho, D; Wallen, E; Xylinas, E; Zigeuner, R; Libertino, J; Evans, C
J UROLOGY. 2014; 191(4): E645-E646.
Abstracts (Zeitschrift)
Targeted treatment beyond third-line in metastatic Renal Cell Carcinoma (mRCC): Single center outcome of 22 patients
Vallet, S; Hofner, T; Pahernik, S; Tosev, G; Hadaschik, B; Duensing, S; Hohenfellner, M; Jager, D; Grullich, C
ONCOL RES TREAT. 2014; 37: 91-91.
Abstracts (Zeitschrift)
SWITCH: a randomized sequential open-label study to evaluate efficacy and safety of sorafenib (SO)/sunitinib (SU) versus SU/SO in the treatment of metastatic renal cell cancer (mRCC)
von Weikersthal, LF; Goebell, PJ; de Santis, M; Lerchenmuller, C; Zimmermann, U; Bos, MMEM; Freier, W; Schirrmacher-Memmel, S; Staehler, M; Pahernik, S; Los, M; Schenck, M; Floercken, A; van Arkel, C; Hauswald, K; Indorf, M; Gottstein, D; Eichelberg, C; Michel, MS
ONCOL RES TREAT. 2014; 37: 5-5.
Abstracts (Zeitschrift)

2013

Beiträge in Fachzeitschriften

Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series.
Brookman-May, S; May, M; Ficarra, V; Kainz, MC; Kampel-Kettner, K; Kohlschreiber, S; Wenzl, V; Schneider, M; Burger, M; Wieland, WF; Otto, W; Tilki, D; Gilfrich, C; Hohenfellner, M; Pahernik, S; Chromecki, TF; Stief, C; Zigeuner, R;
World J Urol. 2013; 31(5): 1309-1316.
Originalarbeiten (Zeitschrift)
Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May, S; May, M; Shariat, SF; Xylinas, E; Stief, C; Zigeuner, R; Chromecki, T; Burger, M; Wieland, WF; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Feciche, B; Truss, M; Gilfrich, C; Pahernik, S; Hohenfellner, M; Zastrow, S; Wirth, MP; Novara, G; Carini, M; Minervini, A; Simeone, C; Antonelli, A; Mirone, V; Longo, N; Simonato, A; Carmignani, G; Ficarra, V;
Eur Urol. 2013; 64(3): 472-477.
Originalarbeiten (Zeitschrift)
Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis.
Brookman-May, S; May, M; Shariat, SF; Zigeuner, R; Chromecki, T; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Feciche, B; Coman, I; Truss, M; Pahernik, S; Wirth, MP; Zastrow, S; Dalpiaz, O; Fenske, F; Waidelich, R; Stief, C; Gunia, S;
Clin Genitourin Cancer. 2013; 11(4): 465-470.
Originalarbeiten (Zeitschrift)
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).
Brookman-May, SD; May, M; Shariat, SF; Novara, G; Zigeuner, R; Cindolo, L; De Cobelli, O; De Nunzio, C; Pahernik, S; Wirth, MP; Longo, N; Simonato, A; Serni, S; Siracusano, S; Volpe, A; Morgia, G; Bertini, R; Dalpiaz, O; Stief, C; Ficarra, V;
BJU Int. 2013; 112(7):909-916
Originalarbeiten (Zeitschrift)
Intraoperative electron radiation therapy (IOERT) in patients with locally recurrent renal cell carcinoma.
Habl, G; Uhl, M; Hensley, F; Pahernik, S; Debus, J; Röder, F;
Radiat Oncol. 2013; 8:282
Originalarbeiten (Zeitschrift)
[Urology in the concept of comprehensive cancer centers].
Hadaschik, B; Pahernik, S; Grüllich, C; Sültmann, H; Jäger, D; von Kalle, C; Duensing, S; Hohenfellner, M;
Urologe A. 2013; 52(9):1283-1289
Übersichtsarbeiten
[Management of prostate cancer in the elderly].
Hatiboglu, G; Hadaschik, B; Teber, D; Duensing, S; Hohenfellner, M; Pahernik, S;
Urologe A. 2013; 52(6):832-837
Originalarbeiten (Zeitschrift)
Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma.
Hatiboglu, G; Pritsch, M; Macher-Goeppinger, S; Zöller, M; Huber, J; Haferkamp, A; Pahernik, S; Wagener, N; Hohenfellner, M;
Scand J Urol. 2013; 47(4):311-322
Originalarbeiten (Zeitschrift)
Development and characteristics of preclinical experimental models for the research of rare neuroendocrine bladder cancer.
Hofner, T; Macher-Goeppinger, S; Klein, C; Rigo-Watermeier, T; Eisen, C; Pahernik, S; Hohenfellner, M; Trumpp, A; Sprick, MR;
J Urol. 2013; 190(6):2263-2270
Originalarbeiten (Zeitschrift)
Two decades" experience with a prospective biobank for urologic oncology: research, clinical care, and the patients" view.
Huber, J; Herpel, E; Jakobi, H; Hadaschik, BA; Pahernik, S; Hohenfellner, M;
Urol Oncol. 2013; 31(7): 990-996.
Originalarbeiten (Zeitschrift)
Multimedia support for improving preoperative patient education: a randomized controlled trial using the example of radical prostatectomy.
Huber, J; Ihrig, A; Yass, M; Bruckner, T; Peters, T; Huber, CG; Konyango, B; Lozankovski, N; Stredele, RJ; Moll, P; Schneider, M; Pahernik, S; Hohenfellner, M;
Ann Surg Oncol. 2013; 20(1): 15-23.
Originalarbeiten (Zeitschrift)
[Novel preclinical models and biomarkers for prostate cancer].
Korzeniewski, N; Tapia-Laliena, M; Tolstov, Y; Pahernik, S; Hadaschik, B; Hohenfellner, M; Duensing, S;
Urologe A. 2013; 52(9): 125-160.
Übersichtsarbeiten
Pediatric case report on magnetic resonance imaging/transrectal ultrasound-fusion biopsy of rhabdomyosarcoma of the bladder/prostate: a new tool to reduce therapy-associated morbidity?
Kuru, TH; Roethke, MC; Nyarangi-Dix, J; Okouoyo, S; Stockklausner, C; Schenk, JP; Debus, J; Roth, W; Teber, D; Pahernik, S; Schlemmer, HP; Hohenfellner, M; Hadaschik, BA;
Urology. 2013; 81(2): 417-420.
Fallberichte
Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru, TH; Roethke, MC; Seidenader, J; Simpfendörfer, T; Boxler, S; Alammar, K; Rieker, P; Popeneciu, VI; Roth, W; Pahernik, S; Schlemmer, HP; Hohenfellner, M; Hadaschik, BA;
J Urol. 2013; 190(4): 1380-1386.
Originalarbeiten (Zeitschrift)
Senescence-associated protein p400 is a prognostic marker in renal cell carcinoma.
Macher-Goeppinger, S; Bermejo, JL; Schirmacher, P; Pahernik, S; Hohenfellner, M; Roth, W;
Oncol Rep. 2013; 30(5):224-253
Originalarbeiten (Zeitschrift)
Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.
May, M; Ficarra, V; Shariat, SF; Zigeuner, R; Chromecki, T; Cindolo, L; Burger, M; Gunia, S; Feciche, B; Wenzl, V; Aziz, A; Chun, F; Becker, A; Pahernik, S; Simeone, C; Longo, N; Zucchi, A; Antonelli, A; Mirone, V; Stief, C; Novara, G; Brookman-May, S;
J Urol. 2013; 190(2):458-463
Originalarbeiten (Zeitschrift)
Impact of complete bladder neck preservation on urinary continence, quality of life and surgical margins after radical prostatectomy: a randomized, controlled, single blind trial.
Nyarangi-Dix, JN; Radtke, JP; Hadaschik, B; Pahernik, S; Hohenfellner, M;
J Urol. 2013; 189(3):891-898
Originalarbeiten (Zeitschrift)
Manual repositioning of intra-atrial kidney cancer tumor thrombus: a technique reducing the need for cardiopulmonary bypass.
Schneider, M; Hadaschik, B; Hallscheidt, P; Jakobi, H; Fritz, M; Motsch, J; Pahernik, S; Hohenfellner, M;
Urology. 2013; 81(4):909-914
Originalarbeiten (Zeitschrift)
Pitfalls of electromagnetic tracking in clinical routine using multiple or adjacent sensors.
Wegner, I; Teber, D; Hadaschik, B; Pahernik, S; Hohenfellner, M; Meinzer, HP; Huber, J;
Int J Med Robot. 2013; 9(3):268-273
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

A PROSPECTIVE MULTICENTER RANDOMIZED STUDY COMPARING GREENLIGHT XPS (TM) LASER AND TRANSURETHRAL RESECTION OF THE PROSTATE FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (GOLIATH): PRELIMINARY PERIOPERATIVE OUTCOME DATA
Bachmann, A; Tubaro, A; Barber, N; DxxxAncona, F; Muir, G; Witzsch, U; Grimm, MO; Benejam, J; Stolzenburg, JU; Riddick, A; Pahernik, S; Roelink, H; Ameye, F; Thomas, A
J UROLOGY. 2013; 189(4): E808-E809.
Abstracts (Zeitschrift)
FEATURES ASSOCIATED WITH RECURRENCE BEYOND 5 YEARS AFTER NEPHRECTOMY AND NEPHRON-SPARING SURGERY FOR RENAL CELL CARCINOMA: DEVELOPMENT AND INTERNAL VALIDATION OF A RISK-MODEL TO PREDICT LATE RECURRENCE BASED ON A LARGE MULTI-CENTER DATABASE (CORONA/SATURN-PROJECT)
Brookman-May, S; May, M; Shariat, S; Novara, G; Zigeuner, R; Cindolo, L; Pahernik, S; Wirth, M; Volpe, A; Stief, C; Ficarra, V
J UROLOGY. 2013; 189(4): E305-E306.
Abstracts (Zeitschrift)
TIME TO RECURRENCE IS A SIGNIFICANT PREDICTOR OF CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RECURRENT RENAL CELL CARCINOMA - RESULTS FROM A COMPREHENSIVE MULTI-CENTER DATABASE (CORONA/SATURN-PROJECT)
Brookman-May, S; May, M; Shariat, S; Novara, G; Zigeuner, R; Cindolo, L; Pahernik, S; Wirth, M; Volpe, A; Stief, C; Ficarra, V
J UROLOGY. 2013; 189(4): E304-E305.
Abstracts (Zeitschrift)
IMPACT OF CLINICAL AND HISTOPATHOLOGICAL PARAMETERS ON DISEASE-SPECIFIC SURVIVAL IN PATIENTS WITH COLLECTING DUCT RENAL CELL CARCINOMA
Brookman-May, S; May, M; Shariat, S; Zigeuner, R; Cindolo, L; Pahernik, S; Volpe, A; Stief, C; Ficarra, V; Becker, A; Gunia, S; Chun, F; Novara, G
J UROLOGY. 2013; 189(4): E440-E441.
Abstracts (Zeitschrift)
Phase III randomized sequential open-label study to evaluate the efficacy and safety of sorafenib followed by pazopanib versus pazopanib followed by sorafenib in the treatment of advanced/metastatic renal cell carcinoma (SWITCH-2 study).
Gschwend, J; Beeker, A; de Santis, M; Brehmer, B; Zaiss, MR; Schirrmacher-Memmel, S; Von Verschuer, U; Bos, MME; Pahernik, S; Grimm, MO; Krause, S; Retz, M
J CLIN ONCOL. 2013; 31(15):
Abstracts (Zeitschrift)
PREOPERATIVE DECISION-MAKING FOR RENAL CELL CARCINOMA: CYSTIC MORPHOLOGY IN CROSS SECTIONAL IMAGING PREDICTS LOWER MALIGNANT POTENTIAL
Huber, J; Winkler, A; Bruckner, T; Roth, W; Hallscheidt, P; Daneshvar, K; Hohenfellner, M; Pahernik, S
J UROLOGY. 2013; 189(4): E260-E260.
Abstracts (Zeitschrift)
LEVEL OF THROMBOUS ACCORDING TO MAYO CLINIC CLASSIFICATION IS AN INDEPENDENT PREDICTOR OF PERIOPERATIVE COMPLICATIONS AND CANCER-RELATED OUTCOME: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM
Martinez-Salamanca, JI; Novara, G; Bertini, R; Carballido, J; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, C; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, T; Lorentz, A; Martinez-Ballesteros, C; Master, V; Matloob, R; McKiernan, J; Mlynarczyk, C; Montorsi, F; Nguyen, H; Pahernik, S; Palou, J; Pruthi, R; Ramaswamy, K; Rodriguez-Faba, O; Russo, P; Spahn, M; Shariat, S; Terrone, C; Tilki, D; Vergho, D; Volpe, A; Wallen, E; Xylinas, E; Zigeuner, R; Libertino, JA
J UROLOGY. 2013; 189(4): E782-E782.
Abstracts (Zeitschrift)
A patient-derived renal cell carcinoma model as a platform for the identification of novel diagnostic markers and therapeutic targets
Rigo-Watermeier, T; Klein, C; Vogel, V; Eisen, C; Hoefner, T; Weichert, W; Pahernik, S; Hohenfellner, M; Sprick, MR; Trumpp, A
CANCER RES. 2013; 73:
Abstracts (Zeitschrift)
INDEPENDENT VALIDATION OF THE 2010 TNM STAGING SYSTEM FOR RENAL CELL CARCINOMA: DOES IT IMPROVES PREDICTIVE ACCURACY IN CANCER-SPECIFIC MORTALITY COMPARED TO 2002 TNM?
Roscigno, M; Shariat, SF; May, M; Novara, G; Zigeuner, R; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Feciche, B; Truss, M; Pahernik, S; Wirth, MP; Longo, N; Simonato, A; Serni, S; Siracusano, S; Volpe, A; Morgia, G; Martorana, G; Francesco, M; Ficarra, V; Brookman-May, S
J UROLOGY. 2013; 189(4): E442-E442.
Abstracts (Zeitschrift)
Phase III randomized sequential open-label study to evaluate the efficacy and safety of sorafenib followed by pazopanib vs pazopanib followed by sorafenib in the treatment of advanced/metastatic renal cell carcinoma - design of the SWITCH-2 Study (NCT01613846)
Schirrmacher-Memmel, S; Retz, M; de Santis, M; Brehmer, B; Zaiss, M; Beeker, A; von Verschuer, U; Bos, M; Pahernik, S; Grimm, MO; Krause, S; Gschwend, J
ONKOLOGIE. 2013; 36: 76-76.
Abstracts (Zeitschrift)
IMPACT OF HISTOLOGIC SUBTYPE ON TUMOR THROMBUS LEVEL AND CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND VENA CAVA THROMBUS
Tilki, D; Dall'Era, MA; Nguyen, HG; Bertini, R; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Lorentz, A; Martinez-Salamanca, JI; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Faba, OR; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP
J UROLOGY. 2013; 189(4): E751-E752.
Abstracts (Zeitschrift)

2012

Beiträge in Fachzeitschriften

PSA density lower cutoff value as a tool to exclude pathologic upstaging in initially diagnosed unilateral prostate cancer: impact on hemiablative focal therapy.
Hofner, T; Pfitzenmaier, J; Alrabadi, A; Pahernik, S; Hadaschik, B; Wagener, N; Djakovic, N; Haferkamp, A; Hohenfellner, M;
World J Urol. 2012; 30(1):91-95
Originalarbeiten (Zeitschrift)
Patients" view of their preoperative education for radical prostatectomy: does it change after surgery?
Huber, J; Ihrig, A; Herzog, W; Huber, CG; Konyango, B; Löser, E; Hatiboglu, G; Hadaschik, BA; Pahernik, S; Hohenfellner, M;
J Cancer Educ. 2012; 27(2):377-382
Originalarbeiten (Zeitschrift)
Multimedia support in preoperative patient education for radical prostatectomy: the physicians" point of view.
Ihrig, A; Herzog, W; Huber, CG; Hadaschik, B; Pahernik, S; Hohenfellner, M; Huber, J;
Patient Educ Couns. 2012; 87(2):239-242
Originalarbeiten (Zeitschrift)
Phantom study of a novel stereotactic prostate biopsy system integrating preinterventional magnetic resonance imaging and live ultrasonography fusion.
Kuru, TH; Roethke, M; Popeneciu, V; Teber, D; Pahernik, S; Zogal, P; Schlemmer, HP; Hadaschik, BA; Hohenfellner, M;
J Endourol. 2012; 26(7):807-813
Originalarbeiten (Zeitschrift)
Renal tumors and second primary pancreatic tumors: a relationship with clinical impact?
Müller, SA; Pahernik, S; Hinz, U; Martin, DJ; Wente, MN; Hackert, T; Leowardi, C; Haferkamp, A; Büchler, MW; Schmied, BM;
Patient Saf Surg. 2012; 6(1):18
Originalarbeiten (Zeitschrift)
Significance of the intraoperative methylene blue test for postoperative evaluation of the vesicourethral anastomosis.
Nyarangi-Dix, JN; Pahernik, S; Bermejo, JL; Prado, L; Hohenfellner, M;
Adv Urol. 2012; 2012:702412
Originalarbeiten (Zeitschrift)
Penile methadone injection in suicidal intent: life-threatening and fatal for erectile function.
Prado, LG; Huber, J; Huber, CG; Mogler, C; Ehrenheim, J; Nyarangi-Dix, J; Pahernik, S; Hohenfellner, M;
J Androl. 2012; 33(5):801-804
Originalarbeiten (Zeitschrift)
Investigation of renal lesions by diffusion-weighted magnetic resonance imaging applying intravoxel incoherent motion-derived parameters--initial experience.
Rheinheimer, S; Stieltjes, B; Schneider, F; Simon, D; Pahernik, S; Kauczor, HU; Hallscheidt, P;
Eur J Radiol. 2012; 81(3):e310-e316
Originalarbeiten (Zeitschrift)
Urinary diversion--approaches and consequences.
Stein, R; Hohenfellner, M; Pahernik, S; Roth, S; Thüroff, JW; Rübben, H;
Dtsch Arztebl Int. 2012; 109(38):617-622
Übersichtsarbeiten

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Thrombocytosis is associated with a significant increase in cancer specific death rate after nephrectomy for patients with renal cell carcinoma
Brookman-May, S; May, M; Burger, M; Denzinger, S; Otto, W; Hoschke, B; Wieland, WF; Rossler, W; Wenzl, V; Kohlschreiber, S; Chromecki, T; Pahernik, S; Hohenfellner, M; Zigeuner, R
EUR UROL SUPPL. 2012; 11(1): E1019-U132.
Abstracts (Zeitschrift)
Collecting system invasion and Fuhrman grading but not tumour size facilitate prognostic stratification of patients with pT2 renal cell carcinoma - can the current 7th edition of TNM classification be improved?
Brookman-May, SD; May, M; Zigeuner, R; Chromecki, T; Shariat, SF; Burger, M; Wieland, WF; Cindolo, L; Wirth, MP; Pahernik, S; Zastrow, S
EUR UROL SUPPL. 2012; 11(1): E1015-U124.
Abstracts (Zeitschrift)
Interdisciplinary counseling service for renal malignancies: Patientsxxx and physiciansxxx view of a new model of care
Huber, J; Ihrig, A; Winkler, E; Grullich, C; Hallscheidt, P; Pahernik, S; Zeier, M; Hohenfellner, M
ONKOLOGIE. 2012; 35: 241-242.
Abstracts (Zeitschrift)
Phase III randomized sequential open-label study to evaluate efficacy and safety of sorafenib (SO) followed by sunitinib (SU) versus sunitinib followed by sorafenib in patients with advanced/metastatic renal cell carcinoma without prior systemic therapy (SWITCH Study): Safety interim analysis results.
Michel, MS; Vervenne, W; Goebell, PJ; Von Weikersthal, LF; Freier, W; De Santis, M; Zimmermann, U; Bos, MMEM; Trojan, L; Lerchenmuller, CA; Schenk, M; Staehler, MD; Florcken, A; Pahernik, S; Los, M; Van Arkel, C; Schirrmacher-Memmel, S; Eichelberg, C
J CLIN ONCOL. 2012; 30(15):
Abstracts (Zeitschrift)
INFLUENCE OF COMPLETE BLADDER NECK PRESERVATION (CBNP) ON CONTINENCE AFTER RADICAL PROSTATECTOMY (RP)-A RANDOMISED CONTROLLED SINGLE-BLINDED TRIAL
Nyarangi-Dix, J; Ehrenheim, J; Pahernik, S; Teber, D; Hohenfellner, M
J UROLOGY. 2012; 187(4): E563-E564.
Abstracts (Zeitschrift)
EFFECT OF COMPLETE BLADDER NECK PRESERVATION ON QUALITY OF LIFE - A RANDOMISED CONTROLLED SINGLE-BLIND TRIAL
Nyarangi-Dix, J; Pahernik, S; Radtke, JP; Teber, D; Hohenfellner, M
J UROLOGY. 2012; 187(4): E153-E153.
Abstracts (Zeitschrift)
INFLUENCE ADJUVANT VS. SALVAGE RADIOTHERAPY ON CONTINENCE AFTER RADICAL PROSTATECTOMY
Nyarangi-Dix, J; Steimer, J; Jakobi, H; Pahernik, S; Hadaschik, B; Hohenfellner, M
J UROLOGY. 2012; 187(4): E386-E386.
Abstracts (Zeitschrift)
Integrated therapy (neoadjuvant) for non-metastatic renal cell carcinoma: a prospective randomized placebo-controlled pilot trial
Pahernik, S; Hatiboglu, G; Huber, J; Husing, J; Hadaschik, B; Hohenfellner, M
ONKOLOGIE. 2012; 35: 235-235.
Abstracts (Zeitschrift)
Identification of Novel Therapeutic Targets in Advanced Patient-matched Renal Cell Carcinoma Models
Rigo-Watermeier, T; Klein, C; Vogel, V; Eisen, C; Hoefner, T; Weichert, W; Pahernik, S; Hohenfellner, M; Sprick, M; Trumpp, A
EUR J CANCER. 2012; 48: S55-S55.
Abstracts (Zeitschrift)
Phase III randomized sequential open-label study to evaluate efficacy and safety of sorafenib (SO) followed by sunitinib (SU) versus sunitinib followed by sorafenib in patients with advanced/metastatic renal cell carcinoma without prior systemic therapy (SWITCH Study) - Safety interim analysis results
von Weikersthal, LF; Vervenne, WL; Goebell, PJ; Eichelberg, C; Freier, W; De Santis, M; Zimmermann, U; Bos, MMEMM; Trojan, L; Lerchenmuller, C; Schenck, M; Staehler, M; Florcken, A; Pahernik, S; Los, M; van Arkel, C; Schirrmacher-Memmel, S; Michel, MS
ONKOLOGIE. 2012; 35: 237-237.
Abstracts (Zeitschrift)

2011

Beiträge in Fachzeitschriften

Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.
Brookman-May, S; May, M; Zigeuner, R; Shariat, SF; Scherr, DS; Chromecki, T; Moch, H; Wild, PJ; Mohamad-Al-Ali, B; Cindolo, L; Wieland, WF; Schips, L; De Cobelli, O; Rocco, B; Santoro, L; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Dalpiaz, O; Hohenfellner, M; Gilfrich, C; Wirth, MP; Burger, M; Pahernik, S;
J Urol. 2011; 186(6):2175-2181
Originalarbeiten (Zeitschrift)
A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion.
Hadaschik, BA; Kuru, TH; Tulea, C; Rieker, P; Popeneciu, IV; Simpfendörfer, T; Huber, J; Zogal, P; Teber, D; Pahernik, S; Roethke, M; Zamecnik, P; Roth, W; Sakas, G; Schlemmer, HP; Hohenfellner, M;
J Urol. 2011; 186(6):2214-2220
Originalarbeiten (Zeitschrift)
Prognostic variables for shockwave lithotripsy (SWL) treatment success: no impact of body mass index (BMI) using a third generation lithotripter.
Hatiboglu, G; Popeneciu, V; Kurosch, M; Huber, J; Pahernik, S; Pfitzenmaier, J; Haferkamp, A; Hohenfellner, M;
BJU Int. 2011; 108(7):1192-1197
Originalarbeiten (Zeitschrift)
Preoperative hydronephrosis predicts advanced bladder cancer but is not an independent factor for cancer-specific survival after radical cystectomy.
Hofner, T; Haferkamp, A; Knapp, L; Pahernik, S; Hadaschik, B; Djakovic, N; Wagener, N; Hohenfellner, M;
Urol Int. 2011; 86(1):25-30
Originalarbeiten (Zeitschrift)
Renal cell cancer--a multimodal approach to preserving renal function and improving survival.
Hohenfellner, M; Pahernik, S; Jaeger, D; Zeier, M;
Nephrol Dial Transplant. 2011; 26(10):3086-3088
Editorials
[Patient centeredness and decision-making in localised prostate cancer: possible fields of health services research in urology].
Huber, J; Ihrig, A; Huber, CG; Hadaschik, B; Pahernik, S; Hohenfellner, M;
Urologe A. 2011; 50(6):691-696
Originalarbeiten (Zeitschrift)
Decision-making in localized prostate cancer: lessons learned from an online support group.
Huber, J; Ihrig, A; Peters, T; Huber, CG; Kessler, A; Hadaschik, B; Pahernik, S; Hohenfellner, M;
BJU Int. 2011; 107(10):1570-1575
Originalarbeiten (Zeitschrift)
Selective transarterial embolization for posttraumatic renal hemorrhage: a second try is worthwhile.
Huber, J; Pahernik, S; Hallscheidt, P; Sommer, CM; Wagener, N; Hatiboglu, G; Haferkamp, A; Hohenfellner, M;
J Urol. 2011; 185(5):1751-1755
Originalarbeiten (Zeitschrift)
Multimedia article. Navigated renal access using electromagnetic tracking: an initial experience.
Huber, J; Wegner, I; Meinzer, HP; Hallscheidt, P; Hadaschik, B; Pahernik, S; Hohenfellner, M;
Surg Endosc. 2011; 25(4):1307-1312
Originalarbeiten (Zeitschrift)
Initial experience with temsirolimus in 2nd-, 3rd- and 4th-line therapy for metastatic renal cell cancer: good clinical response.
Kuru, TH; Huber, J; Hatiboglu, G; Wagener, N; Pahernik, S; Hadaschik, B; Hohenfellner, M;
Urol Int. 2011; 86(3):25-60
Originalarbeiten (Zeitschrift)
Small renal cell carcinoma: oncological outcome with tumour size.
Pahernik, S; Huber, J; Pfitzenmaier, J; Haferkamp, A; Hohenfellner, M;
Scand J Urol Nephrol. 2011; 45(6):432-435
Originalarbeiten (Zeitschrift)
Combining open and laparoscopic surgery for partial nephrectomy.
Pahernik, S; Reiter, M; Hatiboglu, G; Huber, J; Pfitzenmaier, J; Haferkamp, A; Hohenfellner, M;
J Endourol. 2011; 25(5):821-824
Originalarbeiten (Zeitschrift)

2010

Beiträge in Fachzeitschriften

Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
Haferkamp, A; Kurosch, M; Pritsch, M; Hatiboglu, G; Macher-Goeppinger, S; Pfitzenmaier, J; Pahernik, S; Wagener, N; Hohenfellner, M;
Ann Surg Oncol. 2010; 17(2):544-551
Originalarbeiten (Zeitschrift)
[Tumours of the Kidney: CT vs. MRI. Nearly equal alternatives with minor differences].
Huber, J; Hallscheidt, P; Wagener, N; Pahernik, S; Haferkamp, A; Hohenfellner, M;
Urologe A. 2010; 49(3):34-50
Originalarbeiten (Zeitschrift)
Risk factors and clinical management of haemorrhage after open nephron-sparing surgery.
Huber, J; Pahernik, S; Hallscheidt, P; Sommer, CM; Hatiboglu, G; Haferkamp, A; Hohenfellner, M;
BJU Int. 2010; 106(10):1488-1493
Originalarbeiten (Zeitschrift)
[Online support groups for localized prostate cancer: qualitative analysis of decision making].
Huber, J; Peters, T; Kessler, A; Ihrig, A; Huber, CG; Hadaschik, B; Pahernik, S; Hohenfellner, M;
Urologe A. 2010; 49(11):1377-1384
Originalarbeiten (Zeitschrift)
Positive surgical margins after partial nephrectomy
Pahernik, S; Hohenfellner, M
NAT REV UROL. 2010; 7(5): 240-242.
Editorials
Imperative and elective indications for nephron-sparing surgery for renal tumors: long-term oncological follow-up.
Roos, FC; Pahernik, S; Brenner, W; Thüroff, JW;
Aktuelle Urol. 2010; 41 Suppl 1:S70-S76
Originalarbeiten (Zeitschrift)

2009

Beiträge in Fachzeitschriften

[Therapy choices of German urologists and radio-oncologists if personally diagnosed with localized prostate cancer].
Gillitzer, R; Hampel, C; Thomas, C; Schmidt, F; Melchior, SW; Pahernik, S; Schmidberger, H; Thuroff, JW
Urologe A. 2009; 48(4):399-407
Originalarbeiten (Zeitschrift)
[Kidney injuries].
Pfitzenmaier, J; Buse, S; Haferkamp, A; Pahernik, S; Djakovic, N; Hohenfellner, M
Unfallchirurg. 2009; 112(3):317-325
Originalarbeiten (Zeitschrift)
Survival in prostate cancer patients > or = 70 years after radical prostatectomy and comparison to younger patients.
Pfitzenmaier, J; Pahernik, S; Buse, S; Haferkamp, A; Djakovic, N; Hohenfellner, M
World J Urol. 2009; 27(5):637-642
Originalarbeiten (Zeitschrift)
Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population?
Pfitzenmaier, J; Pritsch, M; Haferkamp, A; Jakobi, H; Fritsch, F; Gilfrich, C; Djakovic, N; Buse, S; Pahernik, S; Hohenfellner, M
BJU Int. 2009; 103(7):877-882
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

PEYRONIExxxS DISEASE - CORRECTION FOLLOWING GEOMETRIC PRINCIPLES
Djakovic, N; Oeztuerk, A; Hadaschik, BA; Plitzenmaier, J; Haferkamp, A; Buse, S; Pahernik, S; Hohenfellner, M
J UROLOGY. 2009; 181(4): 382-382.
Abstracts (Zeitschrift)
INLAY-ONLAY URETHROPLASTY IN SEVERE HYPOSPADIAS
Djakovic, N; Oeztuerk, A; Stredele, R; Nyarangi-Dix, J; Haferkamp, A; Pfitzenmaier, J; Pahernik, S; Buse, S; Hohenfellner, M
J UROLOGY. 2009; 181(4): 385-385.
Abstracts (Zeitschrift)
IMPACT OF BMI ON EXTRACORPOREAL SHOCK WAVE TREATMENT FOR KIDNEY STONES-RESULTS FOR 3RD GENERATION LITHOTRIPTERS
Hatiboglu, G; Popeneciu, V; Kurosch, M; Pahernik, S; Haferkamp, A; Hohenfellner, M
J ENDOUROL. 2009; 23: A34-A34.
Abstracts (Zeitschrift)
SMALL RENAL MASSES: ONCOLOGICALLY SIGNIFICANT
Pahernik, S; Pfitzenmaier, J; Haferkamp, A; Hohenfellner, M
EUR UROL SUPPL. 2009; 8(4): 154-154.
Abstracts (Zeitschrift)

2008

Beiträge in Fachzeitschriften

Prognostic stratification of localized renal cell carcinoma by tumor size.
Bedke, J; Pritsch, M; Buse, S; Jakobi, H; Elsaesser, KH; Pahernik, S; Haferkamp, A; Hohenfellner, M
J UROLOGY. 2008; 180(1): 62-67.
Originalarbeiten (Zeitschrift)
Manifestation of congenital urethral diverticula in a 57-year-old male.
Gillitzer, R; Hampel, C; Schede, J; Pahernik, S; Melchior, SW; Thuroff, JW
UROL INT. 2008; 81(2): 238-240.
Fallberichte
Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
Pahernik, S; Roos, F; Rohrig, B; Wiesner, C; Thuroff, JW
J Urol. 2008; 179(1):71-74
Originalarbeiten (Zeitschrift)
[Kidney trauma].
Pfitzenmaier, J; Buse, S; Haferkamp, A; Pahernik, S; Djakovic, N; Hohenfellner, M
Urologe A. 2008; 47(6):759-767
Originalarbeiten (Zeitschrift)
Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL.
Pfitzenmaier, J; Gilfrich, C; Pritsch, M; Herrmann, D; Buse, S; Haferkamp, A; Djakovic, N; Pahernik, S; Hohenfellner, M
BJU Int. 2008; 102(3):322-327
Originalarbeiten (Zeitschrift)
Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?
Pfitzenmaier, J; Pahernik, S; Tremmel, T; Haferkamp, A; Buse, S; Hohenfellner, M
BJU Int. 2008; 102(10):1413-1418
Originalarbeiten (Zeitschrift)
[Elective organ-sparing surgery for renal tumors in patients with a normal contralateral kidney: long-term results].
Roos, FC; Pahernik, S; Brenner, W; Thuroff, JW
Urologe A. 2008; 47(7):824, 826-9
Originalarbeiten (Zeitschrift)
[Imperative nephron-sparing surgery for cases of solitary kidney/bilateral tumors: long-term results].
Roos, FC; Pahernik, S; Elsasser, A; Victor, A; Brenner, W; Thuroff, JW
Urologe A. 2008; 47(7):818-823
Originalarbeiten (Zeitschrift)
Renal tumour surgery in elderly patients.
Roos, FC; Pahernik, S; Melchior, SW; Thuroff, JW
BJU Int. 2008; 102(6):680-683
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Therapy choices of 1600 urologists and radiooncologists if personally diagnosed with localized prostate cancer (PCa)
Gillitzer, R; Pahernik, S; Hampel, C; Schmidt, F; Thomas, C; Melchior, SI; Schmidberger, H; Thuroff, JW
J UROLOGY. 2008; 179(4): 399-399.
Abstracts (Zeitschrift)
Multivariate analysis of patients treated with radical cystectomy evaluating newly proposed prognostic factors for bladder cancer specific survival
Hofner, T; Haferkamp, A; Knapp, L; Jakobi, H; Bedke, J; Pahernik, S; Hohenfellner, M
J UROLOGY. 2008; 179(4): 550-551.
Abstracts (Zeitschrift)

2007

Beiträge in Fachzeitschriften

Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
Pahernik, S; Cudovic, D; Roos, F; Melchior, SW; Thuroff, JW
BJU Int. 2007; 100(1):26-29
Originalarbeiten (Zeitschrift)
Nephron sparing surgery for renal cell carcinoma in a solitary kidney.
Pahernik, S; Roos, F; Wiesner, C; Thuroff, JW
World J Urol. 2007; 25(5):513-517
Originalarbeiten (Zeitschrift)
Small renal tumors: correlation of clinical and pathological features with tumor size.
Pahernik, S; Ziegler, S; Roos, F; Melchior, SW; Thuroff, JW
J Urol. 2007; 178(2):414-417
Originalarbeiten (Zeitschrift)
Long-term follow-up of submucosal tunnel and serosa-lined extramural tunnel ureter implantation in ileocaecal continent cutaneous urinary diversion (Mainz pouch I).
Wiesner, C; Pahernik, S; Stein, R; Hahn, K; Franzaring, L; Melchior, SW; Thuroff, JW
BJU Int. 2007; 100(3):633-637
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Molecular gene expression of M2 and M3 muscarinic receptors in human detrusor tissue associated with subvesical obstruction and detrusor instability
Hampel, C; Schneider Monteiro, E; Pahernik, S; Thuroff, JW
EUR UROL SUPPL. 2007; 6(2): 33-33.
Abstracts (Zeitschrift)
Small renal tumors of a diameter up to 4 cm: Correlation of clinical and pathologic features with tumor size
Roos, F; Ziegler, S; Pahernik, S; Melchior, SW; Thuroff, JW
EUR UROL SUPPL. 2007; 6(2): 160-160.
Abstracts (Zeitschrift)

2006

Beiträge in Fachzeitschriften

[Urethroplasty and simultaneous perineal prostatectomy after traumatic urethral disruption and carcinoma of the prostate].
Gillitzer, R; Hampel, C; Pahernik, S; Melchior, SW; Thuroff, JW
UROLOGE. 2006; 45(9): 1181-1183.
Fallberichte
Pudendal nerve branch injury during radical perineal prostatectomy
Gillitzer, R; Hampel, C; Wiesner, C; Pahernik, S; Melchior, SW; Thuroff, JW
UROLOGY. 2006; 67(2): 4231-4233.
Fallberichte
Rectosigmoid pouch (Mainz Pouch II) in children.
Pahernik, S; Beetz, R; Schede, J; Stein, R; Thuroff, JW
J Urol. 2006; 175(1):284-287
Originalarbeiten (Zeitschrift)
Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience.
Pahernik, S; Roos, F; Hampel, C; Gillitzer, R; Melchior, SW; Thuroff, JW
J Urol. 2006; 175(6):2027-2031
Originalarbeiten (Zeitschrift)
Conversion from colonic conduit into recto-sigmoid pouch (Mainz pouch II).
Pahernik, S; Wiesner, C; Gillitzer, R; Stein, R; Thuroff, JW
BJU Int. 2006; 97(1):157-160
Originalarbeiten (Zeitschrift)
Continent cutaneous urinary diversion: long-term follow-up of more than 800 patients with ileocecal reservoirs.
Wiesner, C; Bonfig, R; Stein, R; Gerharz, EW; Pahernik, S; Riedmiller, H; Thuroff, JW
World J Urol. 2006; 24(3):315-318
Originalarbeiten (Zeitschrift)
Long-term followup of the intussuscepted ileal nipple and the in situ, submucosally embedded appendix as continence mechanisms of continent urinary diversion with the cutaneous ileocecal pouch (Mainz pouch I).
Wiesner, C; Stein, R; Pahernik, S; Hahn, K; Melchior, SW; Thuroff, JW
J Urol. 2006; 176(1):155-159
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Continent urinary diversion with the cutaneous ileocecal pouch and antirefluxing uretero-intestinal reimplantation by a submucosal tunnel or a serosa lined extramural tunnel
Wiesner, C; Pahernik, S; Stein, R; Hahn, K; Schede, J; Franzaring, L; Melchior, SW; Thuroff, JW
J UROLOGY. 2006; 175(4): 49-49.
Abstracts (Zeitschrift)

2005

Beiträge in Fachzeitschriften

[Drug therapy of female urinary incontinence].
Hampel, C; Gillitzer, R; Pahernik, S; Melchior, SW; Thuroff, JW
Urologe A. 2005; 44(3):244-255
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Long-term follow-up of ileal nipple and appendix stoma for continence mechanism in the cutaneous ileocecal pouch (MAINZ 1)
Wiesner, C; Stein, R; Pahernik, S; Hahn, K; Franzaring, L; Melchior, SW; Thuroff, JW
J UROLOGY. 2005; 173(4): 133-133.
Abstracts (Zeitschrift)

2004

Beiträge in Fachzeitschriften

Complete gangrene of penis in patient with arterial vascular disease
Gillitzer, R; Franzaring, L; Hampel, C; Pahernik, S; Bittinger, F; Thuroff, JW
UROLOGY. 2004; 64(6):
Fallberichte
Conversion from colonic or ileal conduit to continent cutaneous urinary diversion.
Pahernik, S; Stein, R; Hohenfellner, M; Thuroff, JW
J Urol. 2004; 171(6 Pt 1):2293-2297
Originalarbeiten (Zeitschrift)
Soluble complement receptor 1 preserves endothelial barrier function and microcirculation in postischemic pancreatitis in the rat.
von Dobschuetz, E; Bleiziffer, O; Pahernik, S; Dellian, M; Hoffmann, T; Messmer, K
Am J Physiol Gastrointest Liver Physiol. 2004; 286(5):G791-G796
Originalarbeiten (Zeitschrift)

2000

Beiträge in Fachzeitschriften

Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma.
Berr, F; Tannapfel, A; Lamesch, P; Pahernik, S; Wiedmann, M; Halm, U; Goetz, AE; Mössner, J; Hauss, J;
J Hepatol. 2000; 32(2): 352-357.
Fallberichte

1998

Beiträge in Fachzeitschriften

Distribution and pharmacokinetics of Photofrin in human bile duct cancer.
Pahernik, SA; Dellian, M; Berr, F; Tannapfel, A; Wittekind, C; Goetz, AE;
J Photochem Photobiol B. 1998; 47(1): 58-62.
Originalarbeiten (Zeitschrift)

1997

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Selective local control of bile duct cancer by photodynamic therapy
Berr, F; Tannapfel, A; Pahernik, S; Wiedmann, M; Lange, K; Halm, U; Dellian, M; Goetz, A; Wittekind, C; Mossner, J
GASTROENTEROLOGY. 1997; 112(4): A538-A538.
Abstracts (Zeitschrift)